Evidence map›Paper›PMID 33841181›Full record

ArticleFrontiers in physiology2021

Serum Zonulin Measured by Commercial Kit Fails to Correlate With Physiologic Measures of Altered Gut Permeability in First Degree Relatives of Crohn's Disease Patients.

Namita Power, Williams Turpin, Osvaldo Espin-Garcia, Michelle I Smith, CCC GEM Project Research Consortium, Kenneth Croitoru

Open access · goldAbstract read
In one paragraph

Article in Frontiers in physiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 2 pooled it
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 2 syntheses or guidelines pooled it, 22 citations in OpenAlex.

  1. Guideline
  2. Pooled it
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Impaired immune response and barrier function in GSPD-1-deficientCurrent research in microbial sciences · 2023
    Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Findings on the Relationship Between Intestinal Microbiome and Vasculitis.Frontiers in cellular and infection microbiology · 2022
    Review
  17. Frontiers in microbiology · 2022
    Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Namita PowerZane Cohen Centre for Digestive Diseases, Mount Sinai Hospital, Toronto, ON, Canada.
Williams TurpinZane Cohen Centre for Digestive Diseases, Mount Sinai Hospital, Toronto, ON, Canada.
Osvaldo Espin-GarciaDivision of Biostatistics, Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada.
Michelle I SmithZane Cohen Centre for Digestive Diseases, Mount Sinai Hospital, Toronto, ON, Canada.
CCC GEM Project Research Consortium
Kenneth CroitoruZane Cohen Centre for Digestive Diseases, Mount Sinai Hospital, Toronto, ON, Canada.
Mount Sinai Hospital · CALunenfeld-Tanenbaum Research Institute · CAPublic Health Ontario · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Intestinal epithelial cell tight junctions (TJs) contribute to the integrity of the intestinal barrier allowing for control of the physical barrier between external antigens or bacterial products and the internal environment. Zonula occludens-1 (ZO-1) is a protein that modulates intestinal TJs, and serum levels of ZO-1 has been suggested as a biomarker of disrupted barrier function in humans. Previous studies suggested that increased intestinal permeability was associated with evidence of TJ abnormalities. However, there is limited information on the serological measurement of ZO-1 and its relation to other tests of barrier function in healthy subjects. We investigated the correlation of serum ZO-1, with physiologic measures of intestinal permeability (as the ratio of the fractional excretion of lactulose-mannitol or LMR) in a cohort of 39 healthy FDRs of Crohn's disease (CD) patients. No significant correlation was found between LMR and ZO-1 levels (

Indexed as

gut barrierinflammatory bowel diseaseintestinal fatty acid binding proteinslactulose-mannitol ratio testzonulin

Identifiers

PMID33841181
PMCPMC8027468
OpenAlexW3148421597

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.